✨
AI Summary
- Abrahão Fecury, CEO of Brazilian telehealth company Eles & Elas, discusses their growth.
- Weight loss treatments, particularly compounded tirzepatide, drive 70% of revenue.
- Fecury shares insights on how Hims & Hers could enter the Brazilian market.
Guests on This Episode
AF
Abrahao Fecury
1 podcast appearance